Self-reported risks for multiple-drug resistance among new tuberculosis cases: Implications for drug susceptibility screening and treatment

17Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

Abstract

Background: Multiple drug-resistance in new tuberculosis (TB) cases accounts for the majority of all multiple drug-resistant TB (MDR-TB) worldwide. Effective control requires determining which new TB patients should be tested for MDR disease, yet the effectiveness of global screening recommendations of high-risk groups is unknown. Methods: Sixty MDR-TB cases with no history of previous TB treatment, 80 drug-sensitive TB and 80 community-based controls were recruited in Lima, Peru between August and December, 2008 to investigate whether recommended screening practices identify individuals presenting with MDR-TB. Odd ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression to study the association of potential risk factors with case/control variables. Results: MDR-TB cases did not differ from drug-sensitive TB and community controls in rates of human immunodeficiency virus infection, reported hospital or prison visits in the 3 years prior to diagnosis. MDR-TB cases were more likely than drug-sensitive TB controls to have had a recent MDR-TB household contact (OR 4.66, (95% CI 1.56-13.87)); however, only 15 cases (28.3%) reported this exposure. In multivariate modeling, recent TB household contact, but not contact with an MDR-TB case, remained predictive of MDR-TB, OR 7.47, (95% CI 1.91-29.3). Living with a partner rather than parents was associated with a lower risk of MDR-TB, OR 0.15, (95% CI 0.04-0.51). Conclusion: Targeted drug susceptibility testing (DST) linked to reported MDR-TB contact or other high-risk exposures does not identify the majority of new TB cases with MDR disease in Lima where it is endemic. All new TB cases should be screened with DST to identify MDR patients. These findings are likely applicable to other regions with endemic MDR-TB. © 2011 Brewer et al.

Figures

  • Table 1. Descriptive statistics of multiple drug-resistant tuberculosis (MDR-TB) cases, drug sensitive tuberculosis (DS-TB) controls and community controls from Lima, Peru, August-December 2008.
  • Table 1. Cont.
  • Table 2. Comparison of exposure risk factors in multiple drug-resistant tuberculosis (MDR-TB) cases with drug-sensitive tuberculosis (DS-TB) controls from Lima, Peru, August-December, 2008.
  • Table 2. Cont.
  • Table 3. Multivariate comparison of exposure risk factors in multiple drug-resistant tuberculosis (MDR-TB) cases with drugsensitive tuberculosis (DS-TB) controls.

References Powered by Scopus

Rapid molecular detection of tuberculosis and rifampin resistance

1903Citations
N/AReaders
Get full text

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

1430Citations
N/AReaders
Get full text

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study

850Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Management of patients with multidrugresistant/ extensively drug-resistant tuberculosis in Europe: A TBNET consensus statement

258Citations
N/AReaders
Get full text

Hepatotoxicity due to first-line anti-tuberculosis drugs: A five-year experience in a Taiwan medical centre

72Citations
N/AReaders
Get full text

Development of multidrug resistant tuberculosis in Bangladesh: A case-control study on risk factors

54Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Brewer, T. F., Choi, H. W., Seas, C., Krapp, F., Zamudio, C., Shah, L., … Gotuzzo, E. (2011). Self-reported risks for multiple-drug resistance among new tuberculosis cases: Implications for drug susceptibility screening and treatment. PLoS ONE, 6(10). https://doi.org/10.1371/journal.pone.0025861

Readers over time

‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2506121824

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 35

58%

Researcher 17

28%

Lecturer / Post doc 5

8%

Professor / Associate Prof. 3

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 30

64%

Nursing and Health Professions 7

15%

Social Sciences 6

13%

Agricultural and Biological Sciences 4

9%

Save time finding and organizing research with Mendeley

Sign up for free
0